RFK Jr. Fires Two Leaders Of Major U.S. Health Task Force

Follow Drugslib on

By Andria Park Huynh HealthDay Reporter

Medically reviewed by Carmen Pope, Senior Medical Editor, B. Pharm. Last updated on May 21, 2026.

via HealthDay

WEDNESDAY, May 13, 2026 — U.S. Health and Human Services Secretary Robert F. Kennedy Jr. has fired two key leaders of the task force that sets insurance coverage rules.

Dr. John Wong, a professor at Tufts University School of Medicine in Boston, and Dr. Esa Davis, a professor at the University of Maryland School of Medicine in Baltimore, were notified by mail that they have been terminated from the U.S. Preventive Services Task Force (USPSTF).

The letters, dated May 11, said the firings were effective immediately to “avoid uncertainty that could jeopardize the validity of future task force actions,” according to The New York Times. The task force determines what preventive care insurers will cover.

Kennedy wrote that his decision followed a review of the current task force and was unrelated to the two leaders' performance, Axios reported. The letters did not explain why the secretary believed the pair’s leadership put future task force actions in jeopardy.

"[T]he Department is taking this step to help protect the Task Force and preserve confidence in the continuity and durability of its work," the letters say.

Davis and Wong were invited to reapply for other positions on the task force, according to The Times — an offer that both took advantage of.

Wong told The Times that during a May 12 meeting with HHS officials, he and Davis were told they had been “prematurely” appointed under the Biden administration.

Their dismissals have sparked concerns among public health experts.

They worry that Kennedy is politicizing the task force, which makes recommendations on such medical services as mammograms, colonoscopies, depression screenings and more based on scientific evidence, said The Times.

The task force also determines what medical screenings and preventive procedures insurers must cover cost-free for millions of Americans under the Affordable Care Act.

Wong and former task force chairman Dr. Michael Silverstein, who left in March at the end of his term, told The Times that the administration had interfered with some of its past recommendations.

As an example, they said the task force was blocked from making public a recommendation endorsing self-testing for cervical cancer as an alternative to Pap smears.

Silverstein likened the interference to Kennedy's overhaul of the Advisory Committee on Immunization Practices (ACIP), which makes vaccine recommendations. Amid court challenges and a legal defeat for HHS, its charter and membership are in flux.

“I am concerned that what the administration did to the ACIP committee, they are doing to the U.S. Preventive Services Task Force, but in slow motion,” Silverstein told The Times.

“The administration came after children’s immunizations, and now it’s coming after our mammograms and our other cancer screenings, and the medical community cannot let this happen,” he added.

Dr. Aaron Carroll, president of AcademyHealth, a health policy research organization, told Axios that he's concerned what these dismissals could mean for the future.

"It could lead to political influence. It could lead to less rigor in the guidelines," he said. "It could lead to evidence being used or misused to not only make recommendations but determine what Americans get covered by insurance without copay, and what prevention they will or will not have."

Sources

  • The New York Times, May 20, 2026
  • Axios, May 20, 2026

    • Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

    Source: HealthDay

    Posted : 2026-05-22 02:48

    Read more

    Disclaimer

    Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

    The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

    Popular Keywords